RVTY Revvity, Inc.
$124.31▲ +2.79%
Healthcare
Other
After hours
$124.31▲ +0.00%
Sep 11, 4:20 PM ET
Volume 1.15M
Avg Volume (10D) 1.72M
Key Metrics & Fundamentals
Market Cap
$13.87B
P/E Ratio
59.8
Div Yield
0.23%
52W Range
81.22 - 133.00
% vs 50 MA
5.93%
% vs 200 MA
20.74%
RSI-14
53.2
MACD Histogram
-0.9500
Beta (1Y vs SPY)
1.26
Free Cash Flow
$180.87M
Gross Rev
$729.69M
Gross Profit
$416.87M
EBITDA
$166.90M
COGS
$312.82M
Operating Exp
$329.01M
Operating Income
$87.85M
EBIT
$87.85M
Pretax Income
$63.53M
Net Income
$51.82M
EPS (Diluted)
0.46
Price & Volume History
Loading chart…
Recent News
Revvity to Acquire Human Cell Design to Boost Metabolic Discovery
Zacks · Sep 11, 2026 3:19 PM
UBS Downgrades Revvity to Neutral From Buy, Adjusts Price Target to $140 From $120
MT Newswires · Sep 9, 2026 1:24 PM
Revvity to Acquire Human Cell Design
MT Newswires · Sep 9, 2026 10:49 AM
Revvity to Acquire Human Cell Design to Advance Human-Relevant Cell Models for Metabolic Disease Drug Discovery
Business Wire · Sep 9, 2026 10:00 AM
Research Use Recombinant Protein Market Report Now Available — Forecasts Market Growth from $1.11B (2026) to $1.55B by 2031, Profiling Thermo Fisher, Bio-Techne, Merck KGaA, Danaher, Revvity, and Others
GlobeNewswire · Sep 8, 2026 2:49 PM
Is Revvity Stock a Buy as Growth Improves but Valuation Stays Rich?
Zacks · Sep 4, 2026 11:49 AM
Global Multiplex Assays Market 2026 Edition - Consumables Dominate Multiplex Assays with 68% Market Share
GlobeNewswire · Sep 4, 2026 9:48 AM
KeyBanc Adjusts Price Target on Revvity to $165 From $125, Maintains Overweight Rating
MT Newswires · Sep 4, 2026 9:33 AM
Baird Adjusts Price Target on Revvity to $144 From $131, Keeps Outperform Rating
MT Newswires · Sep 3, 2026 11:37 AM
Revvity (RVTY) Stock Looks Fair On Cash Flow Yet Pricey On Earnings
Simply Wall St. · Sep 3, 2026 2:14 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See RVTY's money flow as a full page
Social Sentiment
Avg +0.77 · 3 posts
NewsDiscussionTradeBNGO is standing on Third Base
r/StockMarket · Dec 20, 2024
The author highlights the significance of the Bionano-Revvity partnership.
positive
+0.70
NewsDiscussionRevvity, Inc…BNGO…Partnership…Takeover?
r/StockMarket · Dec 19, 2024
The partnership is viewed positively, and the company's size is highlighted as a key factor.
positive
+0.70
NewsEarningsTradeMarket Recap Today 07/29/2024
r/wallstreetbets · Jul 29, 2024
Revvity's performance was discussed, beating analyst expectations.
positive
+0.90
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.